Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.99.7 (
sialyltransferase
)
1,534
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proteolytic and
sialyltransferase
activities were determined in extracts of 65 human primary breast tumors, 6 lymph node metastases, 6 fibroadenomas and 27 normal tissues. Using proteins and synthetic selective substrates, we observed the presence of collagen-peptidases, plasminogen activator,
cathepsin
-B and
cathepsin
-D-like enzymes, and
sialyltransferase
. No active or trypsin-activatable type-IV collagenase activity was detected. Although individual variations between tumors were large, proteinase and
sialyltransferase
contents were significantly elevated in malignant breast tissues. Enzyme activities were found to be related to the epithelial volume of the tumor. No significant correlation was found between the proteinase or
sialyltransferase
activities and the degree of differentiation of the tumor cells, or the degree to which tumors had metastasized to regional lymph nodes. Since large variations of enzyme levels apparently reflect the heterogeneity of epithelial cell densities in tumor samples, proteolytic or
sialyltransferase
activities cannot therefore be used as a measure of quantitative evaluation of invasive properties in breast cancer.
...
PMID:Proteinases and sialyltransferase in human breast tumors. 632 71